Article
A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150).
Molecular pharmacology - 1 Jan 1993
Mellors J W, Im G J, Tramontano E, Winkler S R, Medina D J, Dutschman G E, Bazmi H Z, Piras G, Gonzalez C J, Cheng Y C
Abstract excerpt
Tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione (TIBO) derivatives (e.g., R82150) are potent, human immunodeficiency virus-1 (HIV-1)-specific, inhibitors of reverse transcriptase (RT) that are undergoing initial evaluation in clinical trials. Because HIV-1 has become resistant to other RT inhibitors, we investigated the potential for viral resistance to TIBO R82150 by serial in vitro passage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.